Geneviève Durrieu
- Toxicology top 0.2%
- Pharmacovigilance and Adverse Drug Reactions 50
- Geriatrics and Gerontology top 1%
- Pharmaceutical Practices and Patient Outcomes 14
- Pharmacology top 2%
- Drug-Induced Adverse Reactions 21
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments 11
-
- Pharmaceutical studies and practices 21
-
- Pharmaceutical Economics and Policy 9
-
- Academic integrity and plagiarism 5
-
- Electroconvulsive Therapy Studies 5
- Co-authors
- Jean‐Louis MontastrucFrançois MontastrucMaryse Lapeyre‐MestreHaleh BagheriAgnès SommetJean‐Michel SénardA RascolEmmanuelle Bondon‐Guitton
- Journals
- Drug Safety (7 papers)European Journal of Clinical Pharmacology (6 papers)Clinical Neuropharmacology (4 papers)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
Geneviève Durrieu
102 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 126
- Toxicology 396
- Geriatrics and Gerontology 225
- Applied Microbiology and Biotechnology 69
- Pharmacology 192
- Neurology 322
Countries citing papers authored by Geneviève Durrieu
This map shows the geographic impact of Geneviève Durrieu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geneviève Durrieu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geneviève Durrieu more than expected).
Fields of papers citing papers by Geneviève Durrieu
This network shows the impact of papers produced by Geneviève Durrieu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geneviève Durrieu. The network helps show where Geneviève Durrieu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Geneviève Durrieu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 76 | |
| 5 | 2020 | 2 | |
| 6 | 2018 | 11 | |
| 7 | 2018 | 4 | |
| 8 | 2016 | 0 | |
| 9 | 2016 | 9 | |
| 10 | 2014 | 9 | |
| 11 | 2013 | 3 | |
| 12 | 2013 | 39 | |
| 13 | 2012 | 2 | |
| 14 | 2009 | 9 | |
| 15 | 2008 | 5 | |
| 16 | 2008 | 1 | |
| 17 | 2005 | 6 | |
| 18 | 2004 | 4 | |
| 19 | 1998 | 17 | |
| 20 | 1990 | 89 |
About Geneviève Durrieu
Geneviève Durrieu is a scholar working on Toxicology, Geriatrics and Gerontology and Pharmacology, having authored 105 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (50 papers), Pharmaceutical studies and practices (21 papers), Drug-Induced Adverse Reactions (21 papers), Pharmaceutical Practices and Patient Outcomes (14 papers), Parkinson's Disease Mechanisms and Treatments (11 papers), Pharmaceutical Economics and Policy (9 papers), Academic integrity and plagiarism (5 papers) and Electroconvulsive Therapy Studies (5 papers). The work is most often cited by research in Toxicology (396 citations), Geriatrics and Gerontology (225 citations) and Applied Microbiology and Biotechnology (69 citations). Geneviève Durrieu has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Jean‐Louis Montastruc, François Montastruc, Maryse Lapeyre‐Mestre, Haleh Bagheri, Agnès Sommet, Jean‐Michel Sénard, A Rascol, Emmanuelle Bondon‐Guitton, M. A. Tran and Christine Damase‐Michel. Their work appears in journals such as Drug Safety, European Journal of Clinical Pharmacology, Clinical Neuropharmacology, Pharmacoepidemiology and Drug Safety and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.